Filing Details

Accession Number:
0001209191-15-015145
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-18 14:05:19
Reporting Period:
2015-02-13
Filing Date:
2015-02-18
Accepted Time:
2015-02-18 14:05:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1305299 Faye Margaret Wilson C/O Biocept, Inc.
5810 Nancy Ridge Drive #150
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-13 4,000 $1.25 9,074 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2015-02-13 4,000 $0.00 4,000 $1.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,000 2015-02-13 2020-02-13 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,417 Indirect By LLC
Common Stock 2,374 Indirect By Reporting Person's retirement account
Footnotes
  1. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.25 per unit.